byUniversity of California - San DiegoMouse pancreatic tumors were significantly smaller after being treated with a combination of KRAS inhibitor MRTX1133 and ERBB inhibitor Afatinib (bottom row
byUniversity of California - San DiegoMouse pancreatic tumors were significantly smaller after being treated with a combination of KRAS inhibitor MRTX1133 and ERBB inhibitor Afatinib (bottom row
by Cactus CommunicationsNeuroendocrine neoplasms (NENs) are rare characterized by variable biology and delayed diagnosis. Researchers from China have now found disparities in the burden of NENs across
by Cactus CommunicationsNeuroendocrine neoplasms (NENs) are rare characterized by variable biology and delayed diagnosis. Researchers from China have now found disparities in the burden of NENs across
byLa Jolla Institute for ImmunologyThe image on the left shows an eight-cell blastomere developed from mouse embryonic stem cells with normal TET function. The image on the right shows the conse
byLa Jolla Institute for ImmunologyThe image on the left shows an eight-cell blastomere developed from mouse embryonic stem cells with normal TET function. The image on the right shows the conse
byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge
byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge
byThomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainObesity is a known risk factor for at least13 types of cancer, in part because it creates ever-present inflammatory state. For
byThomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainObesity is a known risk factor for at least13 types of cancer, in part because it creates ever-present inflammatory state. For
by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva
by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva
byGerman Cancer Research CenterWeight Change Among Cases and Controls Within 12 Years Before Diagnosis/Interview Lower and upper hinges correspond to 25th and 75th quantile of weight changes, re
byGerman Cancer Research CenterWeight Change Among Cases and Controls Within 12 Years Before Diagnosis/Interview Lower and upper hinges correspond to 25th and 75th quantile of weight changes, re
by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent
by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent
byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid
byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid
by Lisa Aubry, Loma Linda University Adventist Health Sciences CenterCredit:JAMA Surgery(2023). DOI: 10.1001/jamasurg.2023.0652Researchers say newly reported cases of cancer diagnoses decl
by Lisa Aubry, Loma Linda University Adventist Health Sciences CenterCredit:JAMA Surgery(2023). DOI: 10.1001/jamasurg.2023.0652Researchers say newly reported cases of cancer diagnoses decl
byNYU Langone HealthCredit: Unsplash/CC0 Public DomainSevere inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study sh
byNYU Langone HealthCredit: Unsplash/CC0 Public DomainSevere inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study sh